_id
690da9d0ccc777a4e85d0879
Ticker
ADOCY
Name
Adocia SA ADR
Exchange
PINK
Address
115 Avenue Lacassagne, Lyon, France, 69003
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.adocia.com
Description
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
Last Close
11.8
Volume
200
Current Price
11.8
Change
0
Last Updated
2026-01-21T21:41:14.587Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
170435664
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-12-31
Revenue
10088955
Cost Of Revenue
10088955
Gross Profit
-
Operating Expenses
107168
Operating Income
9981787
Interest Expense
-
Pretax Income
2187744
Net Income
-407022
Eps
-0.026299999444305232
Dividends Per Share
-
Shares Outstanding
14443700
Income Tax Expense
2594766
EBITDA
13017137
Operating Margin
98.93776907519162
Total Other Income Expense Net
-7794043
Cash
7533000
Short Term Investments
-
Receivables
8730000
Inventories
220000
Total Current Assets
22449000
Property Plant Equipment
3118000
Total Assets
27019000
Payables
2200000
Short Term Debt
3259000
Long Term Debt
1950000
Total Liabilities
30108000
Equity
-3090000
Bs_currency_symbol
EUR
Depreciation
243000
Change In Working Capital
-7407000
Cash From Operations
-5331000
Capital Expenditures
52000
Cash From Investing
-65000
Cash From Financing
2599000
Net Change In Cash
7533000
Cf_currency_symbol
-
PE
-
PB
-59.09975391585761
ROE
13.172233009708739
ROA
-1.506428809356379
FCF
-5383000
Fcf Percent
-0.5335537724174605
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
0.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
10088955
Quarters > 0 > income Statement > cost Of Revenue
10088955
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
107168
Quarters > 0 > income Statement > operating Income
9981787
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
2187744
Quarters > 0 > income Statement > net Income
-407022
Quarters > 0 > income Statement > eps
-0.026299999444305232
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
15476122
Quarters > 0 > income Statement > income Tax Expense
2594766
Quarters > 0 > income Statement > EBITDA
13017137
Quarters > 0 > income Statement > operating Margin
98.93776907519162
Quarters > 0 > income Statement > total Other Income Expense Net
-7794043
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
7533000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
8730000
Quarters > 0 > balance Sheet > inventories
220000
Quarters > 0 > balance Sheet > total Current Assets
22449000
Quarters > 0 > balance Sheet > property Plant Equipment
3118000
Quarters > 0 > balance Sheet > total Assets
27019000
Quarters > 0 > balance Sheet > payables
2200000
Quarters > 0 > balance Sheet > short Term Debt
3259000
Quarters > 0 > balance Sheet > long Term Debt
1950000
Quarters > 0 > balance Sheet > total Liabilities
30108000
Quarters > 0 > balance Sheet > equity
-3090000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-376000
Quarters > 0 > cash Flow > depreciation
243000
Quarters > 0 > cash Flow > change In Working Capital
-7407000
Quarters > 0 > cash Flow > cash From Operations
-5331000
Quarters > 0 > cash Flow > capital Expenditures
52000
Quarters > 0 > cash Flow > cash From Investing
-65000
Quarters > 0 > cash Flow > cash From Financing
2599000
Quarters > 0 > cash Flow > net Change In Cash
7533000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.026299999444305232
Quarters > 0 > ratios > PB
-59.09975391585761
Quarters > 0 > ratios > ROE
13.172233009708739
Quarters > 0 > ratios > ROA
-1.506428809356379
Quarters > 0 > ratios > FCF
-5383000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.5335537724174605
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
1445000
Quarters > 1 > income Statement > cost Of Revenue
274537
Quarters > 1 > income Statement > gross Profit
1170463
Quarters > 1 > income Statement > operating Expenses
10229775
Quarters > 1 > income Statement > operating Income
-8273998
Quarters > 1 > income Statement > interest Expense
754438
Quarters > 1 > income Statement > pretax Income
-11230111
Quarters > 1 > income Statement > net Income
-8945000
Quarters > 1 > income Statement > eps
-0.6236507321638679
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
14342964
Quarters > 1 > income Statement > income Tax Expense
-2285111
Quarters > 1 > income Statement > EBITDA
-8148998
Quarters > 1 > income Statement > operating Margin
-572.5950173010381
Quarters > 1 > income Statement > total Other Income Expense Net
-2956113
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
10331000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
111000
Quarters > 1 > balance Sheet > inventories
493000
Quarters > 1 > balance Sheet > total Current Assets
18798000
Quarters > 1 > balance Sheet > property Plant Equipment
3306000
Quarters > 1 > balance Sheet > total Assets
23657000
Quarters > 1 > balance Sheet > payables
1276000
Quarters > 1 > balance Sheet > short Term Debt
3143000
Quarters > 1 > balance Sheet > long Term Debt
3245000
Quarters > 1 > balance Sheet > total Liabilities
31359000
Quarters > 1 > balance Sheet > equity
-7702000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-8945000
Quarters > 1 > cash Flow > depreciation
252000
Quarters > 1 > cash Flow > change In Working Capital
-771000
Quarters > 1 > cash Flow > cash From Operations
-10281000
Quarters > 1 > cash Flow > capital Expenditures
177000
Quarters > 1 > cash Flow > cash From Investing
-193000
Quarters > 1 > cash Flow > cash From Financing
7843000
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.6236507321638679
Quarters > 1 > ratios > PB
-21.97441900804986
Quarters > 1 > ratios > ROE
116.13866528174499
Quarters > 1 > ratios > ROA
-37.81121866677939
Quarters > 1 > ratios > FCF
-10458000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-7.237370242214533
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
565698
Quarters > 2 > income Statement > cost Of Revenue
9730439
Quarters > 2 > income Statement > gross Profit
-9164741
Quarters > 2 > income Statement > operating Expenses
-434820
Quarters > 2 > income Statement > operating Income
-8729921
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-14489658
Quarters > 2 > income Statement > net Income
-12730910
Quarters > 2 > income Statement > eps
-0.9553974597099492
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
13325250
Quarters > 2 > income Statement > income Tax Expense
-1757666
Quarters > 2 > income Statement > EBITDA
-14196533
Quarters > 2 > income Statement > operating Margin
-1543.2122793433953
Quarters > 2 > income Statement > total Other Income Expense Net
-5759736
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
12961000
Quarters > 2 > balance Sheet > short Term Investments
1000
Quarters > 2 > balance Sheet > receivables
111000
Quarters > 2 > balance Sheet > inventories
132000
Quarters > 2 > balance Sheet > total Current Assets
20212000
Quarters > 2 > balance Sheet > property Plant Equipment
3095000
Quarters > 2 > balance Sheet > total Assets
24956000
Quarters > 2 > balance Sheet > payables
3974000
Quarters > 2 > balance Sheet > short Term Debt
2427000
Quarters > 2 > balance Sheet > long Term Debt
4541000
Quarters > 2 > balance Sheet > total Liabilities
31870000
Quarters > 2 > balance Sheet > equity
-6913000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-11770000
Quarters > 2 > cash Flow > depreciation
271000
Quarters > 2 > cash Flow > change In Working Capital
4141000
Quarters > 2 > cash Flow > cash From Operations
-1665000
Quarters > 2 > cash Flow > capital Expenditures
18000
Quarters > 2 > cash Flow > cash From Investing
8500
Quarters > 2 > cash Flow > cash From Financing
2483000
Quarters > 2 > cash Flow > net Change In Cash
833000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.9553974597099492
Quarters > 2 > ratios > PB
-22.745255316071173
Quarters > 2 > ratios > ROE
184.15897584261535
Quarters > 2 > ratios > ROA
-51.01342362558102
Quarters > 2 > ratios > FCF
-1683000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-2.975085646404972
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
1758114
Quarters > 3 > income Statement > cost Of Revenue
11985870
Quarters > 3 > income Statement > gross Profit
-10227755
Quarters > 3 > income Statement > operating Expenses
92930
Quarters > 3 > income Statement > operating Income
-10320685
Quarters > 3 > income Statement > interest Expense
1505257
Quarters > 3 > income Statement > pretax Income
-12040980
Quarters > 3 > income Statement > net Income
-10148872
Quarters > 3 > income Statement > eps
-1.109266354616673
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
9149175
Quarters > 3 > income Statement > income Tax Expense
-1893188
Quarters > 3 > income Statement > EBITDA
-10289350
Quarters > 3 > income Statement > operating Margin
-587.0316145596929
Quarters > 3 > income Statement > total Other Income Expense Net
-1720294
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
12128000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
433000
Quarters > 3 > balance Sheet > inventories
121000
Quarters > 3 > balance Sheet > total Current Assets
16640000
Quarters > 3 > balance Sheet > property Plant Equipment
2778000
Quarters > 3 > balance Sheet > total Assets
21000000
Quarters > 3 > balance Sheet > payables
6550000
Quarters > 3 > balance Sheet > short Term Debt
18628000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
39433000
Quarters > 3 > balance Sheet > equity
-18433000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-9392000
Quarters > 3 > cash Flow > depreciation
228000
Quarters > 3 > cash Flow > change In Working Capital
4734000
Quarters > 3 > cash Flow > cash From Operations
-3285000
Quarters > 3 > cash Flow > capital Expenditures
138000
Quarters > 3 > cash Flow > cash From Investing
-155000
Quarters > 3 > cash Flow > cash From Financing
-1854000
Quarters > 3 > cash Flow > net Change In Cash
-5294000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.109266354616673
Quarters > 3 > ratios > PB
-5.85690148103944
Quarters > 3 > ratios > ROE
55.05816741713232
Quarters > 3 > ratios > ROA
-48.32796190476191
Quarters > 3 > ratios > FCF
-3423000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.9469727219054054
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
9321000
Annuals > 0 > income Statement > cost Of Revenue
1120000
Annuals > 0 > income Statement > gross Profit
8201000
Annuals > 0 > income Statement > operating Expenses
15605000
Annuals > 0 > income Statement > operating Income
-7404000
Annuals > 0 > income Statement > interest Expense
961000
Annuals > 0 > income Statement > pretax Income
-8369000
Annuals > 0 > income Statement > net Income
-9321000
Annuals > 0 > income Statement > eps
-0.6294545422867373
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
14808059
Annuals > 0 > income Statement > income Tax Expense
952000
Annuals > 0 > income Statement > EBITDA
-6913000
Annuals > 0 > income Statement > operating Margin
-79.43353717412295
Annuals > 0 > income Statement > total Other Income Expense Net
-965000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
7533000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
8730000
Annuals > 0 > balance Sheet > inventories
220000
Annuals > 0 > balance Sheet > total Current Assets
22449000
Annuals > 0 > balance Sheet > property Plant Equipment
3118000
Annuals > 0 > balance Sheet > total Assets
27019000
Annuals > 0 > balance Sheet > payables
2200000
Annuals > 0 > balance Sheet > short Term Debt
3259000
Annuals > 0 > balance Sheet > long Term Debt
1950000
Annuals > 0 > balance Sheet > total Liabilities
30108000
Annuals > 0 > balance Sheet > equity
-3090000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-9321000
Annuals > 0 > cash Flow > depreciation
495000
Annuals > 0 > cash Flow > change In Working Capital
-8178000
Annuals > 0 > cash Flow > cash From Operations
-15612000
Annuals > 0 > cash Flow > capital Expenditures
229000
Annuals > 0 > cash Flow > cash From Investing
-258000
Annuals > 0 > cash Flow > cash From Financing
10442000
Annuals > 0 > cash Flow > net Change In Cash
-5428000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.6294545422867373
Annuals > 0 > ratios > PB
-56.54857482200648
Annuals > 0 > ratios > ROE
301.6504854368932
Annuals > 0 > ratios > ROA
-34.49794588992931
Annuals > 0 > ratios > FCF
-15841000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.6994957622572686
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2150000
Annuals > 1 > income Statement > cost Of Revenue
765000
Annuals > 1 > income Statement > gross Profit
1385000
Annuals > 1 > income Statement > operating Expenses
15629000
Annuals > 1 > income Statement > operating Income
-14244000
Annuals > 1 > income Statement > interest Expense
1308000
Annuals > 1 > income Statement > pretax Income
-21160000
Annuals > 1 > income Statement > net Income
-21162000
Annuals > 1 > income Statement > eps
-1.9098261013177096
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
11080590
Annuals > 1 > income Statement > income Tax Expense
2000
Annuals > 1 > income Statement > EBITDA
-19353000
Annuals > 1 > income Statement > operating Margin
-662.5116279069767
Annuals > 1 > income Statement > total Other Income Expense Net
-6916000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
12961000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
251000
Annuals > 1 > balance Sheet > inventories
132000
Annuals > 1 > balance Sheet > total Current Assets
20212000
Annuals > 1 > balance Sheet > property Plant Equipment
3095000
Annuals > 1 > balance Sheet > total Assets
24956000
Annuals > 1 > balance Sheet > payables
2464000
Annuals > 1 > balance Sheet > short Term Debt
1817000
Annuals > 1 > balance Sheet > long Term Debt
4541000
Annuals > 1 > balance Sheet > total Liabilities
31870000
Annuals > 1 > balance Sheet > equity
-6913000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-21162000
Annuals > 1 > cash Flow > depreciation
499000
Annuals > 1 > cash Flow > change In Working Capital
10172000
Annuals > 1 > cash Flow > cash From Operations
-4950000
Annuals > 1 > cash Flow > capital Expenditures
156000
Annuals > 1 > cash Flow > cash From Investing
-138000
Annuals > 1 > cash Flow > cash From Financing
629000
Annuals > 1 > cash Flow > net Change In Cash
-4461000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-1.9098261013177096
Annuals > 1 > ratios > PB
-18.9137801244033
Annuals > 1 > ratios > ROE
306.1189064082164
Annuals > 1 > ratios > ROA
-84.79724314794038
Annuals > 1 > ratios > FCF
-5106000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-2.3748837209302325
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
11447000
Annuals > 2 > income Statement > cost Of Revenue
1839000
Annuals > 2 > income Statement > gross Profit
9608000
Annuals > 2 > income Statement > operating Expenses
11305000
Annuals > 2 > income Statement > operating Income
-12896000
Annuals > 2 > income Statement > interest Expense
2859000
Annuals > 2 > income Statement > pretax Income
-6425000
Annuals > 2 > income Statement > net Income
-6901000
Annuals > 2 > income Statement > eps
-0.8592388471084017
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
8031527
Annuals > 2 > income Statement > income Tax Expense
476000
Annuals > 2 > income Statement > EBITDA
-3576000
Annuals > 2 > income Statement > operating Margin
-112.6583384292828
Annuals > 2 > income Statement > total Other Income Expense Net
-4727000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
17422000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
467000
Annuals > 2 > balance Sheet > inventories
137000
Annuals > 2 > balance Sheet > total Current Assets
26261000
Annuals > 2 > balance Sheet > property Plant Equipment
2856000
Annuals > 2 > balance Sheet > total Assets
30613000
Annuals > 2 > balance Sheet > payables
6414000
Annuals > 2 > balance Sheet > short Term Debt
15671000
Annuals > 2 > balance Sheet > long Term Debt
17539000
Annuals > 2 > balance Sheet > total Liabilities
43583000
Annuals > 2 > balance Sheet > equity
-12969000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-6901000
Annuals > 2 > cash Flow > depreciation
557000
Annuals > 2 > cash Flow > change In Working Capital
-372000
Annuals > 2 > cash Flow > cash From Operations
-14995000
Annuals > 2 > cash Flow > capital Expenditures
153000
Annuals > 2 > cash Flow > cash From Investing
21864000
Annuals > 2 > cash Flow > cash From Financing
-4611000
Annuals > 2 > cash Flow > net Change In Cash
2259000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.8592388471084017
Annuals > 2 > ratios > PB
-7.307581047112345
Annuals > 2 > ratios > ROE
53.21150435654253
Annuals > 2 > ratios > ROA
-22.54271061313821
Annuals > 2 > ratios > FCF
-15148000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.3233161527037651
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1444000
Annuals > 3 > income Statement > cost Of Revenue
1264000
Annuals > 3 > income Statement > gross Profit
180000
Annuals > 3 > income Statement > operating Expenses
19545000
Annuals > 3 > income Statement > operating Income
-19366000
Annuals > 3 > income Statement > interest Expense
2249000
Annuals > 3 > income Statement > pretax Income
-22754000
Annuals > 3 > income Statement > net Income
-22754000
Annuals > 3 > income Statement > eps
-3.2240421673090003
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
7057600
Annuals > 3 > income Statement > income Tax Expense
166000
Annuals > 3 > income Statement > EBITDA
-19347000
Annuals > 3 > income Statement > operating Margin
-1341.1357340720222
Annuals > 3 > income Statement > total Other Income Expense Net
-3388000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
15163000
Annuals > 3 > balance Sheet > short Term Investments
-1000
Annuals > 3 > balance Sheet > receivables
703000
Annuals > 3 > balance Sheet > inventories
517000
Annuals > 3 > balance Sheet > total Current Assets
22084000
Annuals > 3 > balance Sheet > property Plant Equipment
971000
Annuals > 3 > balance Sheet > total Assets
30054000
Annuals > 3 > balance Sheet > payables
3835000
Annuals > 3 > balance Sheet > short Term Debt
16194000
Annuals > 3 > balance Sheet > long Term Debt
18285000
Annuals > 3 > balance Sheet > total Liabilities
43869000
Annuals > 3 > balance Sheet > equity
-13815000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-22754000
Annuals > 3 > cash Flow > depreciation
1158000
Annuals > 3 > cash Flow > change In Working Capital
1297000
Annuals > 3 > cash Flow > cash From Operations
-19234000
Annuals > 3 > cash Flow > capital Expenditures
361000
Annuals > 3 > cash Flow > cash From Investing
-361000
Annuals > 3 > cash Flow > cash From Financing
6644000
Annuals > 3 > cash Flow > net Change In Cash
-12951000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-3.2240421673090003
Annuals > 3 > ratios > PB
-6.028207021353602
Annuals > 3 > ratios > ROE
164.7050307636627
Annuals > 3 > ratios > ROA
-75.71038796832369
Annuals > 3 > ratios > FCF
-19595000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-13.56994459833795
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.026299999444305232
Valuation > metrics > PB
-59.09975391585761
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
13.172233009708739
Profitability > metrics > ROA
-1.8130963517305894
Profitability > metrics > Net Margin
-0.040343325944064576
Profitability > final Score
26
Profitability > verdict
Weak
Risk > metrics > Debt Equity
-
Risk > metrics > Interest Coverage
0.9217309779043017
Risk > final Score
34
Risk > verdict
High
Liquidity > metrics > Current Ratio
-
Liquidity > metrics > Quick Ratio
-
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-14
Prev Risks > 1
-89
Prev Risks > 2
3
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-21T21:41:15.260Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-15
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-25
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.02
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.02
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-10-30
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-09-19
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-04-24
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
-0.62
Earnings History > 5 > eps Difference
0.62
Earnings History > 5 > surprise Percent
100
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-10-25
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
3.46
Earnings History > 6 > eps Difference
-3.46
Earnings History > 6 > surprise Percent
-100
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-09-18
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
-0.6
Earnings History > 7 > eps Difference
0.6
Earnings History > 7 > surprise Percent
100
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-04-25
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
-1.56
Earnings History > 8 > eps Difference
1.56
Earnings History > 8 > surprise Percent
100
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2023-03-15
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-1.41
Earnings History > 9 > eps Estimate
-1.41
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-10-25
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.7215
Earnings History > 10 > eps Estimate
-0.72
Earnings History > 10 > eps Difference
-0.0015
Earnings History > 10 > surprise Percent
-0.2083
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-09-19
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
-0.82
Earnings History > 11 > eps Difference
0.82
Earnings History > 11 > surprise Percent
100
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-04-19
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-1.51
Earnings History > 12 > eps Estimate
-1.51
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2021-09-30
Earnings History > 13 > report Date
2021-10-26
Earnings History > 13 > date
2021-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-1.47
Earnings History > 13 > eps Estimate
-1.09
Earnings History > 13 > eps Difference
-0.38
Earnings History > 13 > surprise Percent
-34.8624
Earnings History > 14 > period
2021-06-30
Earnings History > 14 > report Date
2021-09-07
Earnings History > 14 > date
2021-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-1.39
Earnings History > 14 > eps Estimate
-1.39
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-03-31
Earnings History > 15 > report Date
2021-04-21
Earnings History > 15 > date
2021-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-1.34
Earnings History > 15 > eps Estimate
-1.08
Earnings History > 15 > eps Difference
-0.26
Earnings History > 15 > surprise Percent
-24.0741
Earnings History > 16 > period
2020-12-31
Earnings History > 16 > report Date
2021-03-18
Earnings History > 16 > date
2020-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-1.3
Earnings History > 16 > eps Estimate
-1.29
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-0.7752
Earnings History > 17 > period
2020-09-30
Earnings History > 17 > report Date
2020-10-20
Earnings History > 17 > date
2020-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-1.46
Earnings History > 17 > eps Estimate
0.8598
Earnings History > 17 > eps Difference
-2.3198
Earnings History > 17 > surprise Percent
-269.8069
Earnings History > 18 > period
2020-06-30
Earnings History > 18 > report Date
2020-07-20
Earnings History > 18 > date
2020-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-1.22
Earnings History > 18 > eps Estimate
-1.22
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2020-03-31
Earnings History > 19 > report Date
2020-04-14
Earnings History > 19 > date
2020-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-1.34
Earnings History > 19 > eps Estimate
-1.33
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-0.7519
Earnings History > 20 > period
2019-12-31
Earnings History > 20 > report Date
2020-03-12
Earnings History > 20 > date
2019-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
-0.9434
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.9434
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-09-30
Earnings History > 21 > report Date
2019-10-22
Earnings History > 21 > date
2019-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2018-09-30
Earnings History > 22 > report Date
2018-10-23
Earnings History > 22 > date
2018-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2017-03-31
Earnings History > 23 > report Date
2017-04-18
Earnings History > 23 > date
2017-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
0
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2016-12-31
Earnings History > 24 > report Date
2017-03-08
Earnings History > 24 > date
2016-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
0
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2016-09-30
Earnings History > 25 > report Date
2016-10-11
Earnings History > 25 > date
2016-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
0
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A2 DOGE staffers at Social Security agency may have violated Hatch Act, DOJ says ABC News
Read more →Women’s, advocacy groups call on Apple, Google to drop X and Grok from app stores By Reuters Investing.com Australia
Read more →Showing 2 of 10
(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Medium
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Adocia SA ADR
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.